Copyright
©The Author(s) 2025.
World J Psychiatry. Feb 19, 2025; 15(2): 99008
Published online Feb 19, 2025. doi: 10.5498/wjp.v15.i2.99008
Published online Feb 19, 2025. doi: 10.5498/wjp.v15.i2.99008
Table 1 Comparison of general information, mean ± SD/n (%)
Characterization | Routine diet group | Personalized nutrition group | χ2/t value | P value |
Age | 69.17 ± 6.77 | 68.42 ± 6.36 | 0.559 | 0.577 |
Sex | 0.168 | 0.682 | ||
Male | 27 (56.25) | 25 (52.08) | ||
Female | 21 (43.75) | 23 (47.92) | ||
Height (cm) | 169.28 ± 11.08 | 170.67 ± 12.42 | 0.579 | 0.564 |
Body mass index | 21.98 ± 1.46 | 22.09 ± 1.35 | 0.385 | 0.701 |
Smoking history | ||||
With | 6 (12.50) | 8 (16.67) | ||
Without | 42 (87.50) | 40 (83.33) | ||
Alcoholism history | 0.103 | 0.749 | ||
With | 5 (10.42) | 6 (12.50) | ||
Without | 43 (89.58) | 42 (87.50) | ||
History of underlying diseases | ||||
Hypertension | 0.844 | 0.358 | ||
With | 11 (22.92) | 15 (31.25) | ||
Without | 37 (77.08) | 33 (68.75) | ||
Diabetes | 0.182 | 0.670 | ||
With | 18 (37.50) | 16 (33.33) | ||
Without | 30 (62.50) | 32 (66.67) | ||
Mini-mental state examination score | 21.46 ± 3.86 | 21.42 ± 3.74 | 0.054 | 0.957 |
Serum osteocalcin (ng/L) | 3.45 ± 1.33 | 3.65 ± 1.08 | 0.813 | 0.418 |
25-hydroxyvitamin D (ng/mL) | 15.34 ± 4.02 | 15.15 ± 3.87 | 0.236 | 0.814 |
Serum calcium (mg/dL) | 8.46 ± 2.34 | 8.62 ± 2.12 | 0.352 | 0.726 |
Procollagen type I N-terminal propeptide (ng/mL) | 73.27 ± 5.28 | 73.18 ± 5.67 | 0.080 | 0.936 |
Beta C-terminal telopeptide of type I collagen (ng/mL) | 0.76 ± 0.13 | 0.75 ± 0.15 | 0.327 | 0.744 |
Bone mineral density score | 1.603 | 0.588 | ||
T score > -1 | 5 (10.42) | 6 (12.50) | ||
-2.5 ≤ T score ≤ -1 | 29 (60.42) | 24 (50.00) | ||
T score < -2.5 | 14 (29.16) | 18 (37.50) |
Table 2 Intra-group comparison of bone mineral density in the routine dietary group before and 12 weeks after intervention, n (%)
After treatment | T score > -1 | -2.5 ≤ T score ≤ -1 | T score < -2.5 | Total | P value |
Before treatment | 0.000 | ||||
T score > -1 | 8 (16.67) | 0 (0.00) | 0 (0.00) | 8 (16.67) | |
-2.5 ≤ T score ≤ -1 | 16 (33.34) | 13 (27.08) | 0 (0.00) | 29 (60.42) | |
T score < -2.5 | 0 (0.00) | 4 (8.34) | 7 (14.58) | 11 (22.92) | |
Total | 24 (50.00) | 17 (35.42) | 7 (14.58) | 48 (100) |
Table 3 Intra-group comparison of bone mineral density in the personalized nutrition group before and 12 weeks after intervention, n (%)
After treatment | T score > -1 | -2.5 ≤ T score ≤ -1 | T score < -2.5 | Total | P value |
Before treatment | 0.001 | ||||
T score > -1 | 6 (12.50) | 0 (0.00) | 0 (0.00) | 6 (12.50) | |
-2.5 ≤ T score ≤ -1 | 13 (27.08) | 11 (22.92) | 0 (0.00) | 24 (50.00) | |
T score < -2.5 | 11 (22.92) | 3 (6.25) | 4 (8.33) | 18 (37.50) | |
Total | 30 (62.50) | 14 (29.17) | 4 (8.33) |
Table 4 Inter-group comparison of bone mineral density between the two groups before and 12 weeks after intervention, n (%)
Routine diet group (n = 48) | Personalized nutrition group (n = 48) | χ2 value | P value | |
6.353 | 0.042 | |||
T score > -1 | 24 (50.00) | 30 (62.50) | ||
-2.5 ≤ T score ≤ -1 | 17 (35.42) | 14 (29.17) | ||
T score < -2.5 | 7 (14.58) | 4 (8.33) |
Table 5 Comparison of mini-mental state examination scores between the two groups before and 12 weeks after intervention, mean ± SD
Routine diet group (n = 48) | Personalized nutrition group (n = 48) | t value | P value | |
Before treatment | 21.46 ± 3.86 | 21.42 ± 3.74 | 0.054 | 0.957 |
After treatment | 25.39 ± 2.86 | 26.48 ± 2.27 | 2.057 | 0.042 |
t value | 6.266 | 8.244 | ||
P value | 0.000 | 0.000 |
- Citation: Wang XL, Zhao YR, Yu Y, Mao ZF, Tan SX, Yu SS. Impact of dietary nutrition regimens based on body composition analysis on bone metabolism in Alzheimer’s disease patients. World J Psychiatry 2025; 15(2): 99008
- URL: https://www.wjgnet.com/2220-3206/full/v15/i2/99008.htm
- DOI: https://dx.doi.org/10.5498/wjp.v15.i2.99008